A randomized phase 1 pharmacokinetic trial comparing the potential biosimilar PF-05280014 with trastuzumab in healthy volunteers (REFLECTIONS B327-01)(1)

AIMS: The pharmacokinetic (PK) similarity between PF-05280014, a proposed trastuzumab biosimilar, trastuzumab sourced from European Union (trastuzumab-EU) or from United States (trastuzumab-US) was evaluated. Safety and immunogenicity were also assessed. METHODS: In this phase 1, double-blind trial...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Br J Clin Pharmacol
Egile Nagusiak: Yin, Donghua, Barker, Kerry B, Li, Ruifeng, Meng, Xu, Reich, Steven D, Ricart, Alejandro D, Rudin, Dan, Taylor, Carrie T, Zacharchuk, Charles M, Hansson, Arne G
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BlackWell Publishing Ltd 2014
Gaiak:
Clinical Trials
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4256618/
https://ncbi.nlm.nih.gov/pubmed/25041377
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12464
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak